...
首页> 外文期刊>Clinical rheumatology >Surgical outcomes and risk factors for postoperative complications in patients with Behcet's disease.
【24h】

Surgical outcomes and risk factors for postoperative complications in patients with Behcet's disease.

机译:白塞病患者的手术结局和术后并发症的危险因素。

获取原文
获取原文并翻译 | 示例
           

摘要

This study aims to investigate surgical outcomes in patients with Behcet's disease (BD) and to identify risk factors for the occurrence of postoperative complications. The medical records of 37 patients with newly diagnosed BD were reviewed retrospectively. All patients fulfilled the International Study Group criteria for diagnosis of BD and underwent surgeries after diagnosis. Demographic, clinical, and laboratory data at the time when surgeries were performed were collected and surgical modalities, postoperative complications, and postoperative medical treatments were evaluated. Forty-three surgeries were performed in 37 patients. During mean follow-up duration of 78.2 +/- 50.3 months, 14 surgeries (32.6%) were complicated by wound dehiscence, infection, and graft occlusion or failure with the mean lag time of 6.0 +/- 4.6 months from surgeries. Cumulative incidence of postoperative complications was 7.7% at 3 months, 25.6% at 6 months, 33.3% at 12 months, and 35.9% at 18 months. Postoperative complications occurred more frequently after surgeries that were performed in patients with positive pathergy test (P < 0.001) and after vascular surgeries than after nonvascular surgeries (P < 0.05). Moreover, surgeries that were followed by glucocorticoids with immunosuppressive agents showed a significantly lower postoperative complication rate compared to those that were followed by glucocorticoids alone and those that were not followed by medical treatment (P < 0.05). Multivariate analysis showed that a positive pathergic reaction (P < 0.05, hazard ratio = 1.91) at the time of surgery and surgeries that were not followed by treatment with glucocorticoids and immunosuppressive agent (P < 0.01, hazard ratio = 2.11) was an independent risk factor for the occurrence of postoperative complications. Our findings suggest that the occurrence of postoperative complications can be reduced when postsurgical immunosuppressive treatment was implemented and that the pathergy test can be used as screening methods for occurrence of postoperative complications in patients with BD.
机译:这项研究的目的是调查白塞病(BD)患者的手术结局,并确定术后并发症发生的危险因素。回顾性分析了37例初诊BD的患者的病历。所有患者均符合国际研究小组诊断BD的标准,并在诊断后进行手术。收集进行手术时的人口统计学,临床和实验室数据,并评估手术方式,术后并发症和术后药物治疗。 37例患者进行了43次手术。在平均随访时间78.2 +/- 50.3个月中,有14例(32.6%)手术因伤口裂开,感染,移植物阻塞或衰竭而复杂化,平均滞后时间为6.0 +/- 4.6个月。术后并发症的累积发生率在3个月时为7.7%,在6个月时为25.6%,在12个月时为33.3%,在18个月时为35.9%。病理反应阳性的患者在手术后(P <0.001)和血管外科手术后发生的并发症比非血管外科手术后发生的发生率更高(P <0.05)。此外,与单独使用糖皮质激素和未接受药物治疗的患者相比,接受糖皮质激素和免疫抑制剂的手术术后并发症发生率显着降低(P <0.05)。多变量分析显示,在手术和手术时未进行糖皮质激素和免疫抑制剂治疗的阳性病理反应(P <0.05,危险比= 1.91)是独立的风险(P <0.01,危险比= 2.11)。术后并发症发生的因素。我们的研究结果表明,实施手术后免疫抑制治疗可以减少术后并发症的发生,并且病理学测试可以用作BD患者术后并发症发生的筛查方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号